NxTAG Respiratory Pathogen Panel, REF: I051C0447
Published October 16, 2024 · Recall initiated: September 5, 2024
Summary
FDA records medical device Class II recall Z-0042-2025, published October 16, 2024 and initiated September 5, 2024. Recalling firm: Luminex Molecular Diagnostics Inc; Status: Ongoing; Reported quantity: 3375; Lot: UDI-DI: 00840487100417. Lot/Expiration: IK051C-0181/ 9/30/2024, IK051C-0182/ 9/30/2024, IK051C-0185/ 9/30/2024, IK051C-0186/ 9/30/2024, IK051C-0187/ 10/31/2024, IK051C-0188/ 10/31/2024, IK051C-0189/ 10/31/2024, IK051C-0190/ 10/31/2024, IK051C-0191/ 10/31/2024, IK051C-0192/ 10/31/2024, IK051C-0193/ 10/31/2024, IK051C-0194/ 10/31/2024, IK051C-0195/ 10/31/2024, IK051C-0196/ 11/30/2024, IK051C-0197/ 12/31/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Respiratory pathogen panel may report an elevated rate (7.6% predicted probability of occurrence) of non-specific hMPV target (human Metapneumovirus) results, risk identified predominantly in clinical samples that present positivity for another target, leading to an erroneous co-infection result, can potentially result in hMPV false positives.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Luminex Molecular Diagnostics Inc
- Distributor
- U Nationwide distribution in the states of OH, CA, NC, WI, TN, TX, MI, NY, MO, FL, MA, NJ, PA, VA, AZ, IL, OK, CO, MN.
- Lot
- UDI-DI: 00840487100417. Lot/Expiration: IK051C-0181/ 9/30/2024, IK051C-0182/ 9/30/2024, IK051C-0185/ 9/30/2024, IK051C-0186/ 9/30/2024, IK051C-0187/ 10/31/2024, IK051C-0188/ 10/31/2024, IK051C-0189/ 10/31/2024, IK051C-0190/ 10/31/2024, IK051C-0191/ 10/31/2024, IK051C-0192/ 10/31/2024, IK051C-0193/ 10/31/2024, IK051C-0194/ 10/31/2024, IK051C-0195/ 10/31/2024, IK051C-0196/ 11/30/2024, IK051C-0197/ 12/31/2024
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- Canada
Related recalls
- FDANxTAG Respiratory Pathogen Panel +SARS-CoV-2, REF: I056C0468October 16, 2024
- FDAInspire Model 4063 Stimulation Lead, component of the Inspire Upper Airway Stimulation (UAS) system.October 16, 2024
- FDAInspire Model 4340 Respiratory Sensing Lead, component of the Inspire Upper Airway Stimulation (UAS) system.October 16, 2024
- FDAMAKO Integrated Cutting System (MICS) HANDPIECE, Catalog Number 209063October 16, 2024
- FDAGE Healthcare Centricity Universal Viewer Zero Footprint Client, Model/Catalog/Code Numbers: a)¿¿¿¿¿October 16, 2024
- FDACheck-Flo Performer Introducer Set, Reference Part Number RCF-5.0-35-45-J, Order Number G27242. PerformerOctober 16, 2024
Questions about this recall
Was NxTAG Respiratory Pathogen Panel, REF: I051C0447 recalled?
Yes. FDA published recall Z-0042-2025 on October 16, 2024. Reported hazard: Respiratory pathogen panel may report an elevated rate (7.6% predicted probability of occurrence) of non-specific hMPV target (human Metapneumovirus) results, risk identified predominantly in clinical samples that present positivity for another target, leading to an erroneous co-infection result, can potentially result in hMPV false positives.
What should I do if I have this product?
Voluntary: Firm initiated · Letter